Newron Pharmaceuticals to take part in H.C. Wainwright 28th conference
Newron Pharmaceuticals S.p.A. said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
MILAN, Italy and MORRISTOWN, N.J., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced…